Web
|
Images
|
News
News Home
US
World
Business
Finance
Industry
Technology
Science
Media & Advertising
Politics/Law
Entertainment
Internet
Health
Sports
Culture
WORLD
Log In
ImmuneWorks Receives Orphan Drug Designation
Have an interest in this Story?
Sign Up for Real-Time email updates
Inside INdiana Business
|
November 02, 2009
Indianapolis-based biotech company ImmuneWorks Inc. says the U.S. Food and Drug Administration has designated one of its drugs for use in populations smaller than 200,000. The drug treats a progressive lung disease that is generally fatal. The Orphan Drug Designation also gives ImmuneWorks a seven y...
Read Full Article
Leave a Comment:
You must be logged in to leave a comment
Log in
|
Register
Most Read World Articles
Abu Dhabi to aid Dubai on "case by case" basis
- Buenos Aires Herald
What will Swiss minaret ban achieve?
- BBC
Saudi floods death toll 103
- Manawatu Standard
Church of Scientology plans Illinois headquarters on Printer's Row: Opening of restored
- Individual.com
Swiss vote on move to ban new minarets
- Central Chronicle
Featured Members
Gordon Kauer
Sales Rep/News/On Air
Broadcasting Industry
Rama Sethu Ranga Nathan
Consultant Sound/Recording Engineer
Music Industry
View more profiles
Access dozens of premium and subscriptions sites
Free!
Download now
.
Advertise
|
Build a News Circle
|
Get News Briefings
|
Congoo News Home
|
Get the Netpass
About Congoo
|
Terms
|
Privacy
|
Need Help?
|
Site Map
Copyright ©2009 Congoo.com. All Rights Reserved.